TIDMRTW

RNS Number : 1152I

RTW Venture Fund Limited

01 December 2022

LEI: 549300Q7EXQQH6KF7Z84

1 December 2022

RTW Venture Fund Limited

Publication of Circular & Convening of EGM

Further to the announcement on 28 November 2022, RTW Venture Fund Limited (the "Company") announces that documentation has been filed with the U.S. Internal Revenue Service to change the Company's tax status, with effect from 1 December 2022, from a "publicly traded partnership" or "PTP" to a corporation for U.S. federal tax purposes ("Tax Election").

A shareholder circular (the "Circular") has been published today on the Company's website at www.rtwfunds.com/venture-fund . In addition, a copy of the Circular has been submitted to the National Storage Mechanism and will shortly be available for viewing online at https://data.fca.org.uk/#/nsm/nationalstoragemechanism .

A notice of an Extraordinary General Meeting ("EGM") is contained in the Circular. At the EGM, Shareholders will be asked (a) to approve the adoption of new articles of incorporation, which will be updated to reflect the U.S. federal tax status of the Company following completion of the Tax Election and the reorganisation; and (b) to ratify the decision of the Board to make the Tax Election.

This information is not intended to be all-inclusive or to render specific professional tax advice. Shareholders are urged to consult with their independent tax advisors to determine the tax consequences. The Company does not provide tax or legal advice.

For Further Information:

 
 RTW Investments, LP                  +44 (0) 77 1741 7711 
 Woody Stileman, Managing Director 
 
 Buchanan                             +44 (0)20 7466 5107 
 Charles Ryland 
 Henry Wilson 
 George Beale 
 
 J.P. Morgan Cazenove                 +44 (0)20 7742 4000 
 William Simmonds 
 Jérémie Birnbaum 
 James Bouverat (Sales) 
 
 BofA Securities                      +44 (0) 20 7628 1000 
 Edward Peel 
 Kieran Millar 
 
 Elysium Fund Management Limited      +44 (0) 14 8181 0100 
 Joanna Duquemin Nicolle, Chief 
  Executive Officer 
 Sadie Morrison, Managing Director 
 
 Morgan Stanley Fund Services USA 
  LLC                                 +1 (914) 225 8885 
 

About RTW Venture Fund Limited:

RTW Venture Fund Limited (LSE: RTW & RTWG) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Venture Fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.

RTW Venture Fund Limited is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.

Visit the RTW website at www.rtwfunds.com for more information.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCFDDFDSEESEDF

(END) Dow Jones Newswires

December 01, 2022 02:00 ET (07:00 GMT)

Rtw Biotech Opportunities (LSE:RTW)
過去 株価チャート
から 2 2024 まで 3 2024 Rtw Biotech Opportunitiesのチャートをもっと見るにはこちらをクリック
Rtw Biotech Opportunities (LSE:RTW)
過去 株価チャート
から 3 2023 まで 3 2024 Rtw Biotech Opportunitiesのチャートをもっと見るにはこちらをクリック